<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04549259</url>
  </required_header>
  <id_info>
    <org_study_id>R56NR019443</org_study_id>
    <nct_id>NCT04549259</nct_id>
  </id_info>
  <brief_title>Multi-Component Intervention to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV</brief_title>
  <official_title>Testing a Multi-Component Intervention to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical College of Wisconsin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Engagement in HIV medical care and adherence to HIV medications are both essential in&#xD;
      improving health outcomes among people living with HIV (PLH), but PLH living in rural&#xD;
      areas-who suffer higher mortality rates than their urban counterparts-can confront multiple&#xD;
      barriers to care engagement and adherence, especially as they face the logistical, medical,&#xD;
      and social challenges associated with aging. This project will pilot test four intervention&#xD;
      components designed to improve care engagement and medication adherence to determine their&#xD;
      impact on health outcomes and quality of life among rural, older PLH. The four intervention&#xD;
      components, adapted from evidence-based interventions and delivered remotely, are: (1)&#xD;
      counselor-facilitated peer social support, (2) HIV stigma reduction, (3) strengths-based case&#xD;
      management, and (4) individually-tailored technology use optimization. The investigators&#xD;
      hypothesize that components will be acceptable to participants, will be feasible to&#xD;
      administer remotely, and will show preliminary impact on (1) the proportion of participants&#xD;
      that have viral suppression and (2) health-related quality of life. Results from this study&#xD;
      will provide us with tools to improve health outcomes for rural older people living with HIV.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 14, 2021</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Viral Load (HemaSpot)</measure>
    <time_frame>3 months</time_frame>
    <description>HIV viral load as measured through use of HemaSpot</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health-Related Quality of Life</measure>
    <time_frame>3 months</time_frame>
    <description>Based on scale scores from the WHOQOL-HIV BREF (O'Connell &amp; Skevington, 2012)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>3 months</time_frame>
    <description>Based on scale score from the 3-item Wilson Adherence Scale (Wilson et al., 2017)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Viral Load (Self-Reported)</measure>
    <time_frame>3 months</time_frame>
    <description>Based on participant's self-report of the date and result of the last viral load test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive Symptoms</measure>
    <time_frame>3 months</time_frame>
    <description>Based on scale scores from the Patient Health Questionnaire-Depression Module (PHQ-9; Kroenke et al., 2001)</description>
  </secondary_outcome>
  <number_of_arms>16</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Social Support + Stigma Reduction + SBCM + Tech Detailing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Support + Stigma Reduction + SBCM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Support + Stigma Reduction + Technology Detailing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Support + Stigma Reduction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Support + SBCM + Technology Detailing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Support + SBCM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Support + Technology Detailing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Support</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stigma Reduction + SBCM + Technology Detailing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stigma Reduction + SBCM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stigma Reduction + Technology Detailing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stigma Reduction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SBCM + Technology Detailing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SBCM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Technology Detailing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV Information Only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This arm will not receive any of the 4 intervention components but will receive information on successfully aging with HIV.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group-Based Social Support</intervention_name>
    <description>This intervention involves weekly support group calls facilitated by a licensed counselor or therapist for 8 consecutive weeks. The calls will last approximately 90 minutes and will include 5-8 individuals per group. Groups will follow pre-determined topic areas, with participants encouraged to explore their feelings about the difficulties associated with normal aging, being HIV-positive, and living with HIV/AIDS as an older adult. Therapists will facilitate mutual support among group members, encourage greater openness and emotional expressiveness, and help participants to improve their social and family support and enhance their quality of life. This intervention is an adaptation of Telephone Supportive-Expressive Group Therapy (Heckman et al., 2013).</description>
    <arm_group_label>Social Support</arm_group_label>
    <arm_group_label>Social Support + SBCM</arm_group_label>
    <arm_group_label>Social Support + SBCM + Technology Detailing</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + SBCM</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + SBCM + Tech Detailing</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + Technology Detailing</arm_group_label>
    <arm_group_label>Social Support + Technology Detailing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIV Stigma Reduction</intervention_name>
    <description>This intervention involves weekly support group calls facilitated by a licensed counselor or therapist for 6 consecutive weeks. The calls will last approximately 60-90 minutes and will include 5-8 individuals per group. This intervention is grounded in minority stress theory and will use cognitive-behavioral strategies to help empower participants to cope with stressful and stigmatizing experiences. Intervention components may include minimizing self-stigmatizing attitudes, reducing engulfment, developing a sense of future and hope, and developing and pursuing meaningful life goals. This intervention is an adaptation of &quot;Ending Self Stigma&quot; (Lucksted et al., 2011).</description>
    <arm_group_label>Social Support + Stigma Reduction</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + SBCM</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + SBCM + Tech Detailing</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + Technology Detailing</arm_group_label>
    <arm_group_label>Stigma Reduction</arm_group_label>
    <arm_group_label>Stigma Reduction + SBCM</arm_group_label>
    <arm_group_label>Stigma Reduction + SBCM + Technology Detailing</arm_group_label>
    <arm_group_label>Stigma Reduction + Technology Detailing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Strengths-Based Case Management (SBCM)</intervention_name>
    <description>The investigators have adapted an individually-tailored strengths-based case management (SBCM) intervention to help address the multiple structural barriers faced by rural older PLH. The adapted intervention, delivered by trained research staff, will include two 60-minute telephone-based SBCM counseling sessions with shorter follow-up phone calls to check-in on progress and help patients navigate identified barriers. The case manager will provide tailored sessions based on individually-identified needs and proximal life stressors. Capitalizing on participants' personal strengths, case managers will help empower participants to navigate issues related to employment, insurance, mental health, housing, or transportation. This may include assistance understanding, applying for, and accessing benefits or programs.</description>
    <arm_group_label>SBCM</arm_group_label>
    <arm_group_label>SBCM + Technology Detailing</arm_group_label>
    <arm_group_label>Social Support + SBCM</arm_group_label>
    <arm_group_label>Social Support + SBCM + Technology Detailing</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + SBCM</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + SBCM + Tech Detailing</arm_group_label>
    <arm_group_label>Stigma Reduction + SBCM</arm_group_label>
    <arm_group_label>Stigma Reduction + SBCM + Technology Detailing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Personalized Technology Detailing</intervention_name>
    <description>Participants will be called by a technology-fluent study staff member, who will assess the current state of their technology literacy, access, and use. Detailing will focus on advancing the participant along the technology use cascade (using the internet, possessing a device and service to access internet at home, using the internet to access their electronic health record and pharmacy services, seeking HIV-related information, and finding social support). Each participant will be provided with personalized assistance based on their local and personal circumstances. Because of the individualized advice provided, there will be a range of contacts between 1 and 5, at customized intervals. Detailing protocols include the option of providing the participant with a tablet including cellular service (for 3 months) when in-home internet service is not available or is cost prohibitive.</description>
    <arm_group_label>SBCM + Technology Detailing</arm_group_label>
    <arm_group_label>Social Support + SBCM + Technology Detailing</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + SBCM + Tech Detailing</arm_group_label>
    <arm_group_label>Social Support + Stigma Reduction + Technology Detailing</arm_group_label>
    <arm_group_label>Social Support + Technology Detailing</arm_group_label>
    <arm_group_label>Stigma Reduction + SBCM + Technology Detailing</arm_group_label>
    <arm_group_label>Stigma Reduction + Technology Detailing</arm_group_label>
    <arm_group_label>Technology Detailing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 50 years or greater&#xD;
&#xD;
          -  Living in a zip code classified as a &quot;Small and Isolated Small Rural Town&quot; area by&#xD;
             Rural-Urban Commuting Area Codes (RUCAs), and/or in a county classified as rural based&#xD;
             on RUCAs, and/or in a county with a score of .4 or higher on the index of relative&#xD;
             rurality (IRR)&#xD;
&#xD;
          -  Living in Alabama, Arkansas, Georgia, Kentucky, Mississippi, Missouri, Oklahoma, South&#xD;
             Carolina, or Tennessee&#xD;
&#xD;
          -  Living with HIV&#xD;
&#xD;
          -  Self-reports (a) having no current HIV medical provider, (b) having not seen their HIV&#xD;
             medical provider in the past 6 months, (c) having missed 1 or more HIV medical&#xD;
             appointments in the past 6 months, (d) not currently taking ART, (e) having missed&#xD;
             more than 2 doses of ART in the past month, (f) not having had a viral load test in&#xD;
             the past 12 months, (g) having a detectable viral load, and/or (h) a quality of life&#xD;
             that is &quot;neither poor nor good,&quot; &quot;poor,&quot; or &quot;very poor&quot;&#xD;
&#xD;
          -  Indicates willingness to participate in support groups&#xD;
&#xD;
          -  Indicates willingness to self-collect a dried blood spot sample&#xD;
&#xD;
          -  Has a telephone at home&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not meeting eligibility criteria described above&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Walsh, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for AIDS Intervention Research, Medical College of Wisconsin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew Petroll, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for AIDS Intervention Research, Medical College of Wisconsin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Walsh</last_name>
    <phone>4149557710</phone>
    <email>jwalsh@mcw.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center for AIDS Intervention Research, Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Walsh</last_name>
      <phone>414-955-7710</phone>
      <email>jwalsh@mcw.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wilson IB, Lee Y, Michaud J, Fowler FJ Jr, Rogers WH. Validation of a New Three-Item Self-Report Measure for Medication Adherence. AIDS Behav. 2016 Nov;20(11):2700-2708.</citation>
    <PMID>27098408</PMID>
  </reference>
  <reference>
    <citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.</citation>
    <PMID>11556941</PMID>
  </reference>
  <reference>
    <citation>O'Connell KA, Skevington SM. An international quality of life instrument to assess wellbeing in adults who are HIV-positive: a short form of the WHOQOL-HIV (31 items). AIDS Behav. 2012 Feb;16(2):452-60. doi: 10.1007/s10461-010-9863-0.</citation>
    <PMID>21181253</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>September 1, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>June 16, 2021</last_update_submitted>
  <last_update_submitted_qc>June 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical College of Wisconsin</investigator_affiliation>
    <investigator_full_name>Jennifer Walsh</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

